Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both...
Read MoreMay 19, 2022
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both...
Read MoreMay 14, 2022
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of...
Read MoreMay 14, 2022
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of...
Read MoreMay 14, 2022
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection...
Read MoreMay 14, 2022
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11...
Read MoreMay 14, 2022
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to...
Read MoreMay 14, 2022
1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection...
Read MoreMay 11, 2022
1. EV71vac showed a vaccine efficacy of 96.8% against EV71-associated diseases. 2. Majority of...
Read MoreMay 10, 2022
1. Short-term increases in concentrations of air pollutants, sulfur dioxide (SO2) and particulate...
Read MoreMay 10, 2022
1. In a retrospective cohort study of individuals who recovered from SARS-CoV-2, BNT162b2...
Read MoreMay 10, 2022
1. SARS-CoV-2 infection-acquired immunity waned after 1 year, but immune protection remained high...
Read MoreMay 5, 2022
1. Loss of sense of smell was more common during a period of delta dominance, while sore throat...
Read MoreMay 3, 2022
1. Compared to prepandemic populations, family members of patients admitted to the intensive care...
Read MoreMay 2, 2022
To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus...
Read MoreApr 30, 2022
1. This population-based cohort study using eleven United Kingdom studies demonstrated that...
Read MoreApr 30, 2022
1. This population-based cohort study demonstrated that there was a 20.7% reduction in cancer care...
Read MoreApr 29, 2022
1. Among adults vaccinated against SARS-CoV-2, there was a persistent and robust T-cell response...
Read MoreApr 28, 2022
1. The risk of hospitalization and death was lower among cases infected with Omicron variant...
Read MoreApr 25, 2022
1. Among a group of US medical students, those with multiple marginalized identities (based on...
Read MoreApr 24, 2022
1. Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng province, South Africa,...
Read More